Spire Healthcare Group (LON:SPI) had its target price cut by JPMorgan Chase & Co. from GBX 339 ($4.68) to GBX 293 ($4.05) in a report released on Monday. The firm currently has a “neutral” rating on the stock. JPMorgan Chase & Co.’s price objective indicates a potential upside of 33.79% from the stock’s previous close.
Other equities analysts have also issued research reports about the company. Liberum Capital raised their price objective on Spire Healthcare Group from GBX 270 ($3.73) to GBX 275 ($3.80) and gave the stock a “hold” rating in a report on Friday, January 26th. Barclays assumed coverage on Spire Healthcare Group in a report on Friday, February 2nd. They set an “equal weight” rating and a GBX 270 ($3.73) price objective on the stock. Numis Securities reaffirmed an “add” rating and set a GBX 296 ($4.09) price objective on shares of Spire Healthcare Group in a report on Tuesday, January 16th. Jefferies Group raised Spire Healthcare Group to a “buy” rating and raised their price target for the stock from GBX 259 ($3.58) to GBX 290 ($4.01) in a report on Wednesday, January 17th. Finally, Berenberg Bank raised Spire Healthcare Group to a “buy” rating and raised their price target for the stock from GBX 270 ($3.73) to GBX 310 ($4.28) in a report on Wednesday, November 29th. One research analyst has rated the stock with a sell rating, four have given a hold rating and three have given a buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus price target of GBX 295.57 ($4.08).
Spire Healthcare Group (SPI) opened at GBX 219 ($3.03) on Monday. The stock has a market capitalization of $880.77 and a PE ratio of 5,475.00. Spire Healthcare Group has a twelve month low of GBX 206.40 ($2.85) and a twelve month high of GBX 362.10 ($5.00).
In related news, insider Justin Ash purchased 46,500 shares of the stock in a transaction that occurred on Tuesday, March 6th. The shares were purchased at an average price of GBX 215 ($2.97) per share, with a total value of £99,975 ($138,125.17).
Spire Healthcare Group Company Profile
Spire Healthcare Group plc is a United Kingdom-based independent hospital group. The Company provides in-patient, daycase and out-patient care from approximately 40 hospitals, 10 clinics and over two specialist care centers across the United Kingdom. The Company also owns and operates a sports medicine, physiotherapy and rehabilitation brand, Perform, and a screening service, Lifescan, as well as national pathology services.
Receive News & Ratings for Spire Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.